Literature DB >> 14619964

Arachidonic acid and colorectal carcinogenesis.

Raymond Jones1, Luis-Alfonso Adel-Alvarez, Osvaldo Rascon Alvarez, Russell Broaddus, Siddhartha Das.   

Abstract

Colorectal carcinoma is a leading cause of cancer related death worldwide. This deadly disease advances through a series of clinical and histopathological stages, initiated by single crypt lesions to small benign tumors and finally to malignancy. Although some progress has been made in elucidating the formation of colorectal tumors at molecular/genetic levels, the possible mechanisms of dietary lipids in inducing and promoting colorectal tumorigenesis are poorly understood. Recent epidemiological studies, however, indicate that lipid-rich diet containing omega-6 fatty acids (i.e. linoleic acid, arachidonic acid, etc.) may somehow be related with the disease process. Rapid metabolism of arachidonic acid, increased activities of phospholipases (i.e. phospholipase-A2s), and the elevated levels of cyclooxygenase (COX) and lipoxygenase (LOX) in colonic cells were reported in various stages of the malignancy, suggesting a possible link between dietary lipids and the incidence of colorectal cancer. The major focus of this review is to delineate the recent findings on enhanced arachidonic acid metabolism and its conversion into eicosanoids during the initiation and progression of colorectal carcinogenesis. In addition, the identification and participation of various phospholipases are also discussed. It is speculated that many of these phospholipases can be used as targets for developing new drugs against colorectal as well as other adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14619964     DOI: 10.1023/a:1026060426569

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  95 in total

Review 1.  Cyclooxygenases: structural, cellular, and molecular biology.

Authors:  W L Smith; D L DeWitt; R M Garavito
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

2.  Role of the cytosolic phospholipase A2-linked cascade in signaling by an oncogenic, constitutively active Ha-Ras isoform.

Authors:  M H Yoo; C H Woo; H J You; S H Cho; B C Kim; J E Choi; J S Chun; B H Jhun; T S Kim; J H Kim
Journal:  J Biol Chem       Date:  2001-04-25       Impact factor: 5.157

3.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

4.  Whole almonds and almond fractions reduce aberrant crypt foci in a rat model of colon carcinogenesis.

Authors:  P A Davis; C K Iwahashi
Journal:  Cancer Lett       Date:  2001-04-10       Impact factor: 8.679

5.  Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis.

Authors:  Yoshimi Kakiuchi; Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Naoki Kawai; Masakazu Yasumaru; Arata Kimura; Masato Komori; Takanobu Irie; Eiji Miyoshi; Yutaka Sasaki; Norio Hayashi; Sunao Kawano; Masatsugu Hori
Journal:  Cancer Res       Date:  2002-03-01       Impact factor: 12.701

6.  Activity of human Delta5 and Delta6 desaturases on multiple n-3 and n-6 polyunsaturated fatty acids.

Authors:  R J de Antueno; L C Knickle; H Smith; M L Elliot; S J Allen; S Nwaka; M D Winther
Journal:  FEBS Lett       Date:  2001-11-30       Impact factor: 4.124

7.  Inhibitors of cyclooxygenase-2 (COX-2) suppressed the proliferation and differentiation of human leukaemia cell lines.

Authors:  Y Nakanishi; R Kamijo; K Takizawa; M Hatori; M Nagumo
Journal:  Eur J Cancer       Date:  2001-08       Impact factor: 9.162

8.  A case-control study of diet and colorectal cancer in a multiethnic population in Hawaii (United States): lipids and foods of animal origin.

Authors:  L Le Marchand; L R Wilkens; J H Hankin; L N Kolonel; L C Lyu
Journal:  Cancer Causes Control       Date:  1997-07       Impact factor: 2.506

9.  Induction of prostaglandin endoperoxide synthase 2 by mitogen-activated protein kinase cascades.

Authors:  A McGinty; M Foschi; Y W Chang; J Han; M J Dunn; A Sorokin
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

Review 10.  Inflammatory bowel disease and colon cancer.

Authors:  B Levin
Journal:  Cancer       Date:  1992-09-01       Impact factor: 6.860

View more
  29 in total

1.  Adipose tissue fatty acid composition and colon cancer: a case-control study.

Authors:  A Giuliani; F Ferrara; M Scimò; F Angelico; L Olivieri; L Basso
Journal:  Eur J Nutr       Date:  2013-11-01       Impact factor: 5.614

2.  Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.

Authors:  Victor Kenyon; Ganesha Rai; Ajit Jadhav; Lena Schultz; Michelle Armstrong; J Brian Jameson; Steven Perry; Netra Joshi; James M Bougie; William Leister; David A Taylor-Fishwick; Jerry L Nadler; Michael Holinstat; Anton Simeonov; David J Maloney; Theodore R Holman
Journal:  J Med Chem       Date:  2011-07-08       Impact factor: 7.446

3.  Peroxisome proliferator-activated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis.

Authors:  Yong-Liang Lu; Gai-Ling Li; Hui-Lian Huang; Jing Zhong; Li-Cheng Dai
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

Review 4.  Phospholipid remodeling and eicosanoid signaling in colon cancer cells.

Authors:  Siddhartha Das; Leobarda Robles Martinez; Suparna Ray
Journal:  Indian J Biochem Biophys       Date:  2014-12       Impact factor: 1.918

5.  Association of a functional polymorphism (Gln261Arg) in 12-lipoxygenase with breast cancer.

Authors:  Vidudala V T S Prasad; Padma Kolli; Divya Moganti
Journal:  Exp Ther Med       Date:  2011-01-20       Impact factor: 2.447

6.  Cancer stem cell phenotype is supported by secretory phospholipase A2 in human lung cancer cells.

Authors:  Daine T Bennett; Xin-Sheng Deng; Jessica A Yu; Marshall T Bell; David C Mauchley; Xianzhong Meng; T Brett Reece; David A Fullerton; Michael J Weyant
Journal:  Ann Thorac Surg       Date:  2014-06-10       Impact factor: 4.330

7.  Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer.

Authors:  M Crous-Bou; G Rennert; R Salazar; F Rodriguez-Moranta; H S Rennert; F Lejbkowicz; L Kopelovich; S M Lipkin; S B Gruber; V Moreno
Journal:  Mutagenesis       Date:  2012-03       Impact factor: 3.000

8.  Phospholipase A2G1B polymorphisms and risk of colorectal neoplasia.

Authors:  Clare Abbenhardt; Elizabeth M Poole; Richard J Kulmacz; Liren Xiao; Karen Curtin; Rachel L Galbraith; David Duggan; Li Hsu; Karen W Makar; Bette J Caan; Lisel Koepl; Robert W Owen; Dominique Scherer; Christopher S Carlson; John D Potter; Martha L Slattery; Cornelia M Ulrich
Journal:  Int J Mol Epidemiol Genet       Date:  2013-09-12

9.  Polymorphisms in arachidonic acid metabolism-related genes and the risk and prognosis of colorectal cancer.

Authors:  Shuying Li; Xiaojuan Zhao; Zhiwei Wu; Ye Li; Lin Zhu; Binbin Cui; Xinshu Dong; Suli Tian; Fulan Hu; Yashuang Zhao
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

10.  Co-expression of COX-2 and 5-LO in primary glioblastoma is associated with poor prognosis.

Authors:  Xingfu Wang; Yupeng Chen; Sheng Zhang; Lifeng Zhang; Xueyong Liu; Li Zhang; Xiaoling Li; Dayang Chen
Journal:  J Neurooncol       Date:  2015-09-03       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.